Methods Of Identifying Hiv Patients Sensitive To Therapy With Gp120 Cd4 Binding Site-Directed Antibodies - EP4244396
The patent EP4244396 was granted to Gilead Sciences on Aug 13, 2025. The application was originally filed on Nov 9, 2021 under application number EP21816279A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4244396
- Application Number
- EP21816279A
- Filing Date
- Nov 9, 2021
- Status
- Granted And Under Opposition
- Jul 11, 2025
- Grant Date
- Aug 13, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents